Durable control of small cell carcinoma of the urinary bladder by gemcitabine and paclitaxel.
Matsui
Yoshiyuki
Y
Department of Urology, Kobe City General Hospital, Japan. ym7856@kchnet.or.jp
Fujikawa
Keita
K
Iwamura
Hiroshi
H
Oka
Hiroya
H
Fukuzawa
Shigeki
S
Takeuchi
Hideo
H
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018288:Carcinoma, Small Cell / Q000188:drug therapy*; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017239:Paclitaxel / Q000008:administration & dosage; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D000972:Antineoplastic Agents, Phytogenic; D003841:Deoxycytidine; D017239:Paclitaxel; D000093542:Gemcitabine